Buscar resultados de ensayos clínicos
Coma - 569 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma Condición: Sarcoma, Alveolar Soft Part Fecha: 2009-07-18 Intervenciones: Drug: AZD2171 Cediranib (AZD2171), a VEGF/KIT tyrosine kinase inhibitor, has demonstrated antitumor acti |
| Completed |
Nombre del estudio: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas Condición:
|
| Completed |
Nombre del estudio: Phase 2 Study in Patients With MiT Tumors Condición:
|
| Active, not recruiting |
Nombre del estudio: Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma Condición:
|
| Not yet recruiting |
Nombre del estudio: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Condición:
Intervenciones: |
| Completed |
Nombre del estudio: CREATE: Cross-tumoral Phase 2 With Crizotinib Condición:
|
| Recruiting |
Nombre del estudio: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Condición:
|
| Completed |
Nombre del estudio: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Condición:
Intervenciones: |
| Completed |
Nombre del estudio: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condición:
Intervenciones: |
| Completed |
Nombre del estudio: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Condición:
Intervenciones: Drug: romidepsin DEP is administered at a dose of 13 mg/m2 as a 4-hour intravenous infusion in the outpa |